Breast Cancer Clinical Trial
Official title:
Phase 2 Randomized Study of a Walking Intervention for Radiation-related Fatigue Among Breast Cancer Patients Receiving Adjuvant Radiation
This multicenter randomized (1:1) phase 2 study is designed to assess the efficacy of the
Walk with Ease exercise program on improving fatigue after adjuvant radiotherapy compared to
usual care in 50 women with stage 0-3 breast cancer who have undergone breast surgery.
Prior to initiation of radiation, during the last week, and 4-6 weeks post radiation, women
in both arms will complete a number of surveys including questionnaires on fatigue, pain,
depression, sleep, and social support. In addition, a blood sample will be collected prior
to, during the last week of radiation, and 4-6 weeks post radiation to explore measures of
inflammatory biomarkers, and their potential association with exercise and fatigue.
Recruitment, consent, and randomization will occur at first postoperative visit with a
radiation oncologist. A 1:1 randomization will occur between WWE program and usual care
(scripted discussion on benefit of exercise during radiotherapy). Prior to initiation of
radiation, women in both arms will complete 68 questions from questionnaires on pain,
depression, sleep, and social support. In addition, peripheral blood will be drawn for
analysis of pre-radiation measures of inflammatory biomarkers. Women randomized to the WWE
program will also receive a daily walking log that they will be asked to fill out and return
on the last week of radiation (6 weeks for standard fractionation and 4.5 weeks for
hypofractionation), and at 4-6 weeks post radiotherapy. Also, on their last week of
radiotherapy and 4-6 weeks after radiotherapy all patients will repeat the questionnaires and
a blood draw for measures of inflammatory biomarkers.
Contact with study participants will be at 3 points in time after enrollment and
randomization:
Baseline: At this meeting, requirements of the study will be reviewed, and study materials
provided (for control arm: a one page explanation discussing the potential benefits of
exercise on fatigue, for experimental arm: WWE workbook, and printed walking log).
Participants will complete questionnaires and undergo other assessments including a blood
draw. For those on the experimental arm, they will be asked to begin the walking program
within a week, noting their walking experience in their daily log.
Last week of radiation: All participants will repeat questionnaires and other assessments
during any day of their last week of radiation. A repeat blood draw will be taken. In
addition those on the WWE arm will have their walking log reviewed. For those receiving
hypofractionated radiotherapy, this will occur at week 4. For those receiving standard
fractionation this will occur at week 6.
4-6 weeks following end of radiation: All participants will repeat questionnaires and other
assessments. A repeat blood draw will be taken. In addition those on the WWE arm will have
their walking log reviewed.
Patients randomized to the usual care arm will receive a document with information on
exercise to improve fatigue during radiotherapy. The sheet will summarize the findings of the
3 randomized studies on exercise intervention during radiotherapy.
The primary activity required of study subjects is a 4-6-week self-directed (non-group) WWE
walking program that participants do at a place and time that is convenient for them.
Participants are asked to walk at a safe and comfortable pace, increasing their minutes per
day at a rate they can sustain, with the ultimate goal of 30 minutes/day for at least 5
days/week. They are asked to maintain a daily walking log that is provided to them, entering
total minutes per day.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |